PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

Biogen launches Cleo™ application to inform and support anyone living with multiple sclerosis

The health and wellbeing application is designed to be a daily digital companion for the MS community and is available to download from today on iPhone and Android.

Maidenhead, UK – 7 March, 2019 – Biogen has today announced the UK launch of its new digital application (app) – Cleo™ – an everyday digital companion to provide information and support for people living with multiple sclerosis (MS), as well as their carers, friends and family.*

The app’s four main features include:

  • Information, articles and stories for people living with MS
  • Personal Journal – a simple way for MS patients to keep track of their health and set treatment and appointment reminders
  • Health and wellbeing programmes designed to help patients living with MS
  • Cleo™ Chat – users can chat with a Cleo™ Advisor who can help them make the most of Cleo™ articles, programmes and features

“Biogen believes that, regardless of treatment choices, patients should always be informed, supported and inspired to aim for better tomorrows. Cleo™ reinforces our ongoing commitment to MS and is an example of our ambition to provide digital solutions that benefit people living with neurological conditions.”

Terry O’Regan, Vice President & Managing Director, Biogen UK & Ireland.

The app was developed by Biogen’s Global digital entity Biogen Healthcare Solutions (BHS) who aim to provide best-in-class digital solutions that improve patient care. Cleo™ is already available

in Germany, France, Italy, Canada, Japan and the US and will evolve regularly to incorporate new content and features based on feedback and input from the MS community. Further country launches are scheduled throughout 2019.

“The MS journey is a complex one, and knowing where to go to find trusted information on health and wellbeing can be a key challenge for patients in the UK. Cleo™ was designed as a simple, personalised mobile solution to support the MS community in keeping track of their health, supporting their wellbeing and learning about the MS topics that matter most to them”

Matt Norcross, Affiliate Head of Multichannel Excellence (UK) at Biogen.

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026